Literature DB >> 22197967

Plasma cytokine levels in children with autistic disorder and unrelated siblings.

A M Manzardo1, R Henkhaus, S Dhillon, M G Butler.   

Abstract

BACKGROUND: The pathogenesis of autistic disorder (AD) is not clearly understood but genetic factors and the immune system have been implicated. Disturbed immunoglobulin levels and autoantibodies to neuronal elements have been reported in AD including cytokines encoded by genes involved with cell proliferation, migration and adhesion but there is a paucity of data comparing cytokine levels in children with AD and unrelated siblings without AD.
METHODS: We analyzed 39 plasma cytokines in 99 well-characterized children with AD between 5 and 10 years of age and 40 age and gender matched healthy unrelated siblings without AD under the same clinical assessments, specimen processing and laboratory conditions. Multiplex sandwich immunoassays were used with the Luminex fluorescent-bead based platform. Log-transformed values of the 29 cytokines meeting laboratory criteria for inclusion were analyzed by analysis of covariance with a general linear model adjusting for diagnosis, gender, diagnosis by gender interaction effects, age and days of specimen handling. The Tukey-Kramer post hoc test was used to control for multiple comparisons.
RESULTS: Eight of 29 cytokine levels analyzed were significantly lower in children with AD compared with unrelated siblings without the diagnosis of AD. Three of the cytokines are known to be involved with hematopoiesis and five with attraction of T-cells, natural killer cells and monocytes.
CONCLUSIONS: Plasma cytokine levels representing chemokines involved in the T-helper cell immune system and hematopoiesis were lower in the children with AD compared with unrelated siblings without AD necessitating further studies to confirm immunological disturbances influencing hematopiesis and antibody production in the children with AD. Linking genes that encode immune related proteins and cytokines are important to study for their impact on critical periods of brain development and function. Copyright Â
© 2011 ISDN. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22197967      PMCID: PMC6675569          DOI: 10.1016/j.ijdevneu.2011.12.003

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  27 in total

Review 1.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 2.  The major histocompatibility complex and autism spectrum disorder.

Authors:  Leigh A Needleman; A Kimberley McAllister
Journal:  Dev Neurobiol       Date:  2012-08-23       Impact factor: 3.964

3.  EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.

Authors:  M G Butler; T A Nelson; D J Driscoll; A M Manzardo
Journal:  J Rare Disord       Date:  2015-09

Review 4.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  A Masi; D S Quintana; N Glozier; A R Lloyd; I B Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

Review 5.  The BTBR T+ tf/J mouse model for autism spectrum disorders-in search of biomarkers.

Authors:  Ksenia Z Meyza; Erwin B Defensor; Ashley L Jensen; Michael J Corley; Brandon L Pearson; Roger L H Pobbe; Valerie J Bolivar; D Caroline Blanchard; Robert J Blanchard
Journal:  Behav Brain Res       Date:  2012-08-09       Impact factor: 3.332

6.  High monocyte level and low lymphocyte to monocyte ratio in autism spectrum disorders.

Authors:  Selma Tural Hesapcioglu; Meryem Kasak; Aysegül Nese Cıtak Kurt; Mehmet Fatih Ceylan
Journal:  Int J Dev Disabil       Date:  2017-09-26

7.  T cell populations in children with autism spectrum disorder and co-morbid gastrointestinal symptoms.

Authors:  Destanie R Rose; Houa Yang; Milo Careaga; Kathy Angkustsiri; Judy Van de Water; Paul Ashwood
Journal:  Brain Behav Immun Health       Date:  2020-01-26

8.  Formation of functional areas in the cerebral cortex is disrupted in a mouse model of autism spectrum disorder.

Authors:  Laura R Fenlon; Sha Liu; Ilan Gobius; Nyoman D Kurniawan; Skyle Murphy; Randal X Moldrich; Linda J Richards
Journal:  Neural Dev       Date:  2015-04-03       Impact factor: 3.842

9.  Lipid mediators in plasma of autism spectrum disorders.

Authors:  Afaf El-Ansary; Laila Al-Ayadhi
Journal:  Lipids Health Dis       Date:  2012-11-21       Impact factor: 3.876

10.  Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children.

Authors:  Laila Yousef Al-Ayadhi; Gehan Ahmed Mostafa
Journal:  J Neuroinflammation       Date:  2013-06-19       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.